ConductScience.org, home

Paper18782877

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Cohen P and 9 others. J Clin Endocrinol Metab, 2008. Cited by 548 papers, by iCite.

Cite this record

ConductScience Library. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. Papers, record 18782877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18782877

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.
PubMed
Journal
J Clin Endocrinol Metab
PubMed
Year
2008
PubMed
Publication types
Consensus Statement, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
548
iCite
Relative citation ratio, by iCite
16.5
iCite
Revised in PubMed
2026-05-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cohen PP
2Rogol ADA D
3Deal CLC L
4Saenger PP
5Reiter EOE O
6Ross JLJ L
7Chernausek SDS D
8Savage MOM O
9Wit JMJ M
102007 ISS Consensus Workshop participantsGroup

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Growth DisordersMajor topic
Adult
Body Height
Body Weight
Child
Endocrinology
Female
Gonadotropin-Releasing Hormone
Humans
Insulin-Like Growth Factor I
Male
Mass Screening
Reference Values

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01237041Free Fatty Acids, Body Weight, and Growth Hormones Secretion in ChildrenBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by283

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 548 citations.

PMIDTitleJournalYearIn PapersSource
42964989Timing of Growth Hormone Therapy Initiation and Final Adult Height in Idiopathic Short Stature: A Systematic Review.Cureus2026https://conductscience.org/library/papers/42964989PubMed
42867492Arguments against the proposed change of the diagnostic term "idiopathic short stature" into "healthy short stature".Arch Endocrinol Metab2026https://conductscience.org/library/papers/42867492PubMed
42827615A novel method based on ultrasound radiomics for predicting attainment of near-adult height in adolescents.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42827615PubMed
42824137Mediating role of peripheral thyroid hormone conversion efficiency in the association between BMI and IGF-1 in children with growth retardation: a cross-sectional study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42824137PubMed
42755462
Case Report: Proportionate short stature in a three-generation family harboring FGFR3 N540S: phenotypic expansion beyond hypochondroplasia and implications for genetic screening in idiopathic short stature.
Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42755462PubMed
42729368Phenotype-specific 25-hydroxyvitamin D and fat-soluble vitamin profiles in girls with pediatric endocrine disorders: a large cross-sectional study.Front Nutr2026https://conductscience.org/library/papers/42729368PubMed
42713069Familial short stature: genetic architecture, risk stratification, and precision management.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42713069PubMed
42687935Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42687935PubMed
42658741International Consensus on the Diagnosis and Clinical Management of Idiopathic Short Stature: A Modified Delphi Method.Horm Res Paediatr2026https://conductscience.org/library/papers/42658741PubMed
42510090
Interpretable Machine Learning for Predicting Suboptimal 12-Month Growth Response to Recombinant Human Growth Hormone in Children with Idiopathic Short Stature: A Dual-Center External Validation Study.
Diagnostics (Basel)2026https://conductscience.org/library/papers/42510090PubMed
42482901Population characteristics of children with short stature and construction of a predictive model for growth hormone treatment efficacy.Front Med (Lausanne)2026https://conductscience.org/library/papers/42482901PubMed
42399260An EHR-based framework for modeling growth curves and constructing growth centile charts for genetic disorders.NPJ Genom Med2026https://conductscience.org/library/papers/42399260PubMed
42394781Evaluation of growth hormone provocative tests in Egyptian children with growth hormone-related short stature.World J Exp Med2026https://conductscience.org/library/papers/42394781PubMed
42371703Goodbye, idiopathic short stature: why "healthy short stature" is a necessary advancement.Arch Endocrinol Metab2026https://conductscience.org/library/papers/42371703PubMed
42371702Healthy short stature.Arch Endocrinol Metab2026https://conductscience.org/library/papers/42371702PubMed
42310355Association between recombinant human growth hormone therapy and refractive status in Korean children with idiopathic short stature: a cross-sectional study.Sci Rep2026https://conductscience.org/library/papers/42310355PubMed
42272566Growth hormone retesting for idiopathic isolated growth hormone deficiency during and after puberty: a systematic review.J Endocr Soc2026https://conductscience.org/library/papers/42272566PubMed
42157165Clinical and genetic profile of achondroplasia: a descriptive study from a tertiary care center in Saudi Arabia.BMC Pediatr2026https://conductscience.org/library/papers/42157165PubMed
42064572Fermented Oyster Extract Improves Linear Growth in Children with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Trial.Prev Nutr Food Sci2026https://conductscience.org/library/papers/42064572PubMed
42060159Association Between Socioeconomic Indicators and Growth Hormone Treatment Patterns for Idiopathic Short Stature in China: A Large-Scale Real-World Study.Adv Ther2026https://conductscience.org/library/papers/42060159PubMed

See all 283 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP19A11588PubTator's text mininghttps://conductscience.org/library/genes/1588NCBI Gene
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18782877

GET https://conductscience.org/api/papers/v1/18782877/cited_by?page=2